· Published by Health Canada · Official notice
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| TARO | TARO-CANDESARTAN | DIN 02380684 | Tablet | CANDESARTAN CILEXETIL 4 MG | PTG4320A PTG4321A |
| TARO | TARO-CANDESARTAN | DIN 02380692 | Tablet | CANDESARTAN CILEXETIL 8 MG | PTF3333A PTF3338A PTF5487A PTF5488A PTF5489A PTF5490A PTF5491A PTF6159A PTG1103A PTG1083A |
| TARO | TARO- CANDESARTAN | DIN 02380706 | Tablet | CANDESARTAN CILEXETIL 16 MG | PTF3339A PTF5498A PTF5497A PTG1386A PTG1387A PTG1388A |
| TARO | TARO-CANDESARTAN | DIN 02380714 | Tablet | CANDESARTAN CILEXETIL 32 MG | PTF3279A PTF3280A PTF3281A PTF3282A PTF3283A |
Affected lots were manufactured using an active ingredient that was out of specification for dissolution.